Cancer Care
Cancer is a disease caused by the abnormal growth of cells in the body. Screening plays a crucial role in detecting cancer in its early stages, as many cancers may not present any symptoms initially. Additionally, genetic testing can help assess an individual’s risk of developing cancer and aid in preventive planning. Risk factors that increase cancer risk include advancing age, genetics, smoking, alcohol consumption, and an unhealthy diet. Maintaining good health through balanced eating, regular exercise, and avoiding risky behaviors is key to cancer prevention.
|
Regular (THB)
|
Special (THB)
|
|---|---|
|
52,926
|
32,900
|
Cancer Check - Female Package
A health check-up that includes screening for common cancers in women, such as cervical, breast, ovarian, liver, and colon cancer, helps prevent and reduce the risk of advanced cancer, thereby increasing the chances of effective treatment.
Cancer Screening in Women
Cancer screening is especially important for women, as it can detect cancer in its early stages, increasing the chances of successful treatment. Common cancers in women and the recommended screening tests include:
- Cervical Cancer Screening (Pap Smear and HPV Test)
Cervical cancer is one of the most common cancers in women. A Pap Smear involves collecting cells from the cervix to check for abnormalities that may lead to cancer. The HPV test checks for the presence of HPV infection, the leading cause of cervical cancer. This test is recommended starting at age 21 and should be done every 3-5 years if results are normal. - Mammogram and Breast Ultrasound
A mammogram is an X-ray of the breast used to screen for breast cancer, the most common cancer in women. Screening is recommended from age 40, or earlier if there is a family history of breast cancer. Mammograms can detect cancer in its early stages even before symptoms appear. For more accurate results, it is often combined with a breast ultrasound. - Pelvic Ultrasound
This test is used to screen for ovarian and uterine cancers, which often do not present symptoms in their early stages. Pelvic ultrasound helps detect abnormalities in the ovaries and uterus. It is recommended for women at high risk or those experiencing symptoms such as chronic abdominal pain or irregular menstruation. - Colonoscopy
Colon cancer affects both women and men. Screening is recommended starting at age 50. A colonoscopy can help detect polyps or other abnormalities in the colon that may develop into cancer. - Lung Cancer Screening (Low–dose CT Scan)
For women who smoke or have smoked, a low-dose CT scan is the recommended screening method, as it can detect lung cancer in its early stages, significantly increasing the chances of effective treatment. - Blood Test for Liver Cancer (AFP Test)
Similar to men, women at risk of liver cancer, particularly those with chronic hepatitis, should undergo an AFP blood test. This screening helps detect liver cancer early.
Regular cancer screening is essential in preventing and reducing the risk of advanced cancer. Following your doctor’s advice for routine health check-ups will help maintain your quality of life and reduce the risk of cancer-related mortality.
Examinations
- Physical Examination (Check-up)
- Pelvic Examination by an Obstetric -Gynaecologist
- Alpha Fetoprotein (AFP)
- Complete Blood Count
- Kidney Function Test: Creatinine (plus eGFR), BUN
- Glucose (Fasting)
- Glycated Hb (HbA1c)
- Hepatitis B Surface Antibody (HBsAb, Anti-HBS)
- Hepatitis B Surface Antigen
- Hepatitis C Antibody
- Lipid Set (Chol, Tri, HDL, LDL)
- Liver Function Test (ALT, AST, ALP, Total Bilirubin, Direct Bilirubin)
- Vitamin D (25-Hydroxy Vitamin D Total)
- Uric Acid
- Urine Examination
- Stool Examination and Occult Blood
- Ultrasound Upper Abdomen
- Ultrasound Lower Abdomen
- CT Chest Low Dose
- EKG (ECG Cardiac)
- Thin Prep Pap Smear + HPV DNA (Co-test)
- Mammograms with Ultrasound Breast
- CA125 ( plus HE4 )
- Cancer Antigen 15-3 (Breast Cancer)
- Carbohydrate Antigen 19-9 (Digestive Tract)
- Carcinoembryonic Antigen (CEA)
- Food Coupon (300 Baht)
- Check-up Report
- Doctor’s Fee and Hospital and Nursing Services Fee
|
Regular (THB)
|
Special (THB)
|
|---|---|
|
37,115
|
21,900
|
Cancer Check - Male Package
A health check-up that includes screening for common cancers in men and women, such as prostate, lung, liver, and colon cancer, helps prevent and reduce the risk of advanced cancer, thereby increasing the chances of effective treatment.
Cancer Screening in Men
Cancer screening is just as important for men as early detection significantly improves treatment outcomes. The most common cancers in men and the recommended screening tests include:
- PSA (Prostate Cancer) Test
The PSA (Prostate-Specific Antigen) test measures the level of PSA, a protein produced by the prostate gland, in the blood. Elevated PSA levels can indicate abnormalities in the prostate, which is a common site for cancer in men aged 50 and older. This test is crucial for detecting prostate cancer at an early stage when treatment is most effective. - Colonoscopy
A colonoscopy examines the colon and rectum for abnormalities and is a key screening tool for colon cancer, one of the most common cancers in men. The test allows doctors to detect polyps or other growths that may become cancerous. This screening is recommended for men starting at age 50. - Chest X–ray (Low–dose CT Scan)
Lung cancer screening is essential for men at high risk, particularly those who currently smoke or have smoked in the past. A low-dose CT scan is more effective than traditional X-rays in detecting lung cancer at earlier stages, thereby helping reduce mortality from lung cancer. - Blood Test for Liver Cancer (AFP Test)
The AFP (Alpha-Fetoprotein) test measures AFP levels in the blood to screen for liver cancer, especially in men with a history of chronic hepatitis or cirrhosis. This test can detect liver cancer early, improving the chances of successful treatment.
These screenings are crucial for preventing and treating cancer in men, as many cancers do not show symptoms in the early stages. Regular health check-ups can reduce the risk of advanced cancer and increase the chances of a complete cure.
Examinations
- Physical Examination (Check-up)
- Alpha Fetoprotein (AFP)
- Complete Blood Count
- Kidney Function Test: Creatinine (plus eGFR), BUN
- Glucose (Fasting)
- Glycated Hb (HbA1c)
- Hepatitis B Surface Antibody (HBsAb, Anti-HBS)
- Hepatitis B Surface Antigen
- Hepatitis C Antibody
- Lipid Set (Chol, Tri, HDL, LDL)
- Liver Function Test (ALT, AST, ALP, Total Bilirubin, Direct Bilirubin)
- Vitamin D (25-Hydroxy Vitamin D Total)
- Uric Acid
- Urine Examination
- Stool Examination and Occult Blood
- Ultrasound Upper Abdomen
- Ultrasound Lower Abdomen
- CT Chest Low Dose
- EKG (ECG Cardiac)
- Prostatic Specific Antigen (PSA)
- Testosterone
- Carbohydrate Antigen 19-9 (Digestive Tract)
- Carcinoembryonic Antigen (CEA)
- Food Coupon (300 Baht)
- Check-up Report
- Doctor’s Fee and Hospital and Nursing Services Fee
|
Regular (THB)
|
Special (THB)
|
|---|---|
|
33,320
|
29,900
|
Hereditary Cancer Screening Package
Screening for gene abnormalities that may increase cancer risk, this test allows for early risk assessment, preventive planning, and more targeted treatment, especially for individuals with a family history of cancer or suspicious symptoms.
Cancer Genetic Testing
Cancer genetic testing identifies gene abnormalities that may increase the likelihood of developing cancer. This test helps assess risk in advance and allows for more accurate prevention and treatment planning, particularly for individuals with a family history of cancer or suspicious symptoms. The test involves analysing blood or tissue samples to guide personalized health care, such as regular check-ups or preventive medications. However, genetic testing only assesses the risk—it does not mean that cancer is certain.
Who should consider cancer genetic testing?
- Individuals with a family history of cancer
- People experiencing abnormal symptoms that may indicate cancer, such as unusual lumps or abnormal bleeding
- Individuals who want to plan for their family, especially if they are concerned about passing on a genetic risk for cancer to their children
84–Gene Cancer Screening
This genetic test assesses the risk of inherited cancers, such as breast, ovarian, colon, uterine, and thyroid cancer. The results can be used to plan personalized cancer screening, prevent the onset of disease, and increase the accuracy of future screenings.
Common cancer types include:
- Breast cancer
- Female reproductive system cancers, such as ovarian and endometrial cancer
- Prostate cancer in men
- Digestive system cancers, such as colon and stomach cancer
- Endocrine system cancers, such as thyroid cancer, endocrine tumors, adrenal tumors, and tumors of the parathyroid and pituitary glands
- Urinary system cancers (kidneys, urinary tract, prostate)
- Skin cancer
- Cancers of the nervous system and brain
- Cellular cancers
- Hematological cancers (myelodysplastic syndromes, leukemia)
Recommended for:
- Individuals with direct relatives who were diagnosed with cancer at a young age, or those with multiple family members across generations affected by cancer. A consultation and genetic screening should be considered.
- Patients with cancer who want to determine if their cancer is linked to a hereditary gene.
- Individuals interested in genetic testing to plan long-term health care.
|
Regular (THB)
|
Special (THB)
|
|---|---|
|
27,820
|
21,500
|
ctDNA Multi-cancer Early Detection Screening Package
Screening for the risk of five types of cancer: breast cancer, lung cancer, liver cancer, colorectal cancer, and stomach cancer, using a technology called Next Generation Sequencing.
Circulating Tumor DNA (ctDNA) Testing
Circulating Tumor DNA (ctDNA) testing is an early cancer risk screening tool that screens for five types of cancer: breast cancer, lung cancer, liver cancer, colorectal cancer, and stomach cancer. It detects the genetic material of cancer cells that have been released into the bloodstream using Next Generation Sequencing (NGS) technology. This method allows for the simultaneous screening of multiple cancers with just a single blood test, even in individuals without symptoms.
Key benefits of ctDNA testing:
- High accuracy, with a specificity of up to 97%.
- Sensitivity of up to 72.4%.
- Simple, convenient, and painless testing method.
- Non-invasive, as it does not rely on traditional biopsies.
- Helps diagnose tumor types and effectively monitors cancer treatment outcomes.
Highlights of ctDNA Testing:
- Cancer diagnosis: ctDNA testing detects DNA with genetic abnormalities, reducing the need for invasive or hard-to-reach biopsies, such as those for brain or lung tumors.
- Treatment planning: Genetic analysis of cancer cells using ctDNA helps doctors select the most appropriate treatment for each patient.
- Treatment monitoring: A decrease in ctDNA levels indicates that the tumor is shrinking and the treatment is working.
- Relapse monitoring: The absence of ctDNA in the bloodstream suggests that the cancer has not returned.
This test is particularly useful for monitoring treatment responses and assessing the risk of cancer recurrence, providing patients with faster and more accurate information to guide their treatment decisions.
